Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biovie (BIVI) Accounts Payables: 2013-2025

Historic Accounts Payables for Biovie (BIVI) over the last 6 years, with Mar 2025 value amounting to $2.5 million.

  • Biovie's Accounts Payables fell 43.86% to $2.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.5 million, marking a year-over-year decrease of 43.86%. This contributed to the annual value of $2.2 million for FY2025, which is 38.66% down from last year.
  • Biovie's Accounts Payables amounted to $2.5 million in Q1 2025, which was up 79.08% from $1.4 million recorded in Q4 2024.
  • Biovie's Accounts Payables' 5-year high stood at $4.8 million during Q1 2023, with a 5-year trough of $679,393 in Q3 2021.
  • Its 3-year average for Accounts Payables is $3.2 million, with a median of $3.1 million in 2023.
  • Per our database at Business Quant, Biovie's Accounts Payables skyrocketed by 415.80% in 2021 and then crashed by 43.86% in 2025.
  • Biovie's Accounts Payables (Quarterly) stood at $1.7 million in 2021, then soared by 95.14% to $3.2 million in 2022, then climbed by 3.52% to $2.7 million in 2023, then increased by 27.19% to $1.4 million in 2024, then crashed by 43.86% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q1 2025, $1.4 million for Q4 2024, and $3.5 million during Q3 2024.